Introductory text
United Kingdom
Commission Implementing Decision (EU) 2019/1664
of 30 September 2019
authorising a laboratory in Ukraine to carry out serological tests to monitor the effectiveness of rabies vaccines in dogs, cats and ferrets
(notified under document C(2019) 6906)
(Text with EEA relevance)
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Council Decision 2000/258/EC of 20 March 2000 designating a specific institute responsible for establishing the criteria necessary for standardising the serological tests to monitor the effectiveness of rabies vaccinesf1, and in particular Article 3(2) thereof,
Whereas:
(1)
Decision 2000/258/EC designates the Agence française de sécurité sanitaire des aliments (AFSSA) in Nancy, France, as the specific institute responsible for establishing the criteria necessary for standardising the serological tests to monitor the effectiveness of rabies vaccines. The AFSSA has now been integrated into the Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail (ANSES) in France.
(2)
Decision 2000/258/EC provides, inter alia, that the ANSES is to appraise laboratories in third countries that have applied for approval to carry out serological tests to monitor the effectiveness of rabies vaccines.
(3)
The competent authority of Ukraine has submitted an application for the approval of the laboratory ‘NeoVetlab Ukraine Ltd’ in Kyiv, and the ANSES has established and submitted to the Commission a favourable appraisal report dated 14 September 2018 for this laboratory.
(4)
The laboratory ‘NeoVetlab Ukraine Ltd’ in Kyiv should therefore be authorised to carry out serological tests to monitor the effectiveness of rabies vaccines in dogs, cats and ferrets.
(5)
The measures provided for in this Decision are in accordance with the opinion of Standing Committee on Plants, Animals, Food and Feed,
HAS ADOPTED THIS DECISION: